Low levels of replicating Epstein-Barr viruses might be the main driver of the autoimmune condition multiple sclerosis. This may mean that targeting them would be as effective as suppressing the ...

Future therapies for respiratory syncytial virus (RSV) must target both the virus and the immune response to ensure babies ...

SHELTON, CT / ACCESS Newswire / July 13, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical ...

The Ebola outbreak in eastern Congo is now the fastest-growing one in history and new challenges keep emerging. A strike this ...

As monsoon-related illnesses surge every year, consumers should not assume that every expense will automatically be reimbursed ...

Fresh COVID-19 cases reported from Uttar Pradesh, Maharashtra and Andhra Pradesh have sparked renewed discussions on social ...

Puppygram said all of their dogs are healthy and up to date with vaccines.

Research and field experience have answered many of the biggest questions surrounding HPAI while reshaping how veterinarians ...

Aligos Therapeutics, Inc. (Nasdaq: ALGS, "Aligos”), a clinical stage biopharmaceutical company focused on developing novel therapeutics to address unmet medical needs in liver and viral diseases, ...

Eighty percent of new Ebola cases in eastern Congo are emerging from unknown chains of transmission, according to WHO, a sign ...